Following the Marburg virus epidemic in Equatorial Guinea, the Nigeria Centre for Disease Control and Prevention has stated that there is a moderate risk of the country importing the disease.
The direct flight between Nigeria and Equatorial Guinea and Equatorial Guinea’s proximity to Nigeria both increase the probability of the virus being imported into Nigeria, but the NCDC also noted that the size of the outbreak in Equatorial Guinea has not yet been determined.
The health organisation added that the gatherings and travel related to the impending national elections are likely to increase the risk of transmission in Nigeria.
NCDC said in a statement;
“There are currently no cases of Marburg virus disease in Nigeria, however, the NCDC, relevant Ministries, Departments, Agencies, and partners have taken proactive measures to mitigate the risk of cross-border importation. The multi-sectoral National Emerging Viral Haemorrhagic Disease Technical Working Group, led by NCDC, is responsible for coordinating the national response to all VHFs across pillars including surveillance, laboratory, case management, and risk communication. The NEVHD TWG like it has always done in the past following news of MVD outbreaks conducted a dynamic risk assessment to inform Nigeria’s preparedness following this recent outbreak in Equatorial Guinea.
“Based on available data, the overall risk of importation of the Marburg virus and the impact on the health of Nigerians has been assessed as MODERATE.
“The risk assessment also shows that Nigeria has the capacity-technical, human (health workforce), and diagnostic – required to respond effectively in the event of an outbreak. Nigeria has also responded to viral haemorrhagic fever epidemics like the Ebola Outbreak in 2014 and built up her preparedness and response capabilities over the years. We have the diagnostic capacity to test for MVD presently at the National Reference Laboratory in Abuja and the University of Lagos Teaching Hospital laboratory Centre for Human and Zoonotic Virology.
“However, diagnostic capacity will be scaled up to other laboratories in cities with important points of entry and others as may be required. An effective response system is in place with the availability of control capacities (trained rapid response teams, and an effective infection prevention and control programme) to limit the risk of spread in the event of a single imported case.
“Persons with recent travel history to or transit through Equatorial Guinea within the past 21 days who experience symptoms such as fever, muscle pain, sore throat, diarrhoea, weakness, vomiting, stomach pain, or unexplained bleeding or bruising should not go to any health facility but call 6232 or their State Ministry of Health hotline immediately for assessment and testing.”
Marburg virus disease is a highly virulent disease that causes haemorrhagic fever, with a fatality ratio of up to 88 per cent. It is in the same family as the virus that causes Ebola virus disease. Illness caused by the Marburg virus begins abruptly, with high fever, severe headache, and severe malaise.
Many patients develop severe haemorrhagic symptoms within seven days. The virus is transmitted to people from fruit bats and spreads among humans through direct contact with the bodily fluids of infected people, surfaces, and materials.
The case fatality rate of MVD ranges between 24 to 88 per cent and it does not currently have an effective drug for treatment or a licensed vaccine for prevention.